ANGIOCEPT
associated with 17 other trademarks
Biotechnology and pharmaceutical products, namely, therapeutic proteins for human use for the treatment and prevention of obesity, diabetes, incontine...

Words that describe this trademark:

obesity diabetes  therapeutic proteins  pharmaceutical products  human treatment  diabetes incontinence  treatment prevention  prevention obesity  biotechnology pharmaceutical  products  proteins 

Serial Number:

77245120

Mark:

ANGIOCEPT

Status:

Abandoned-No Statement of Use filed

Status Date:

09-26-2011

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Biotechnology and pharmaceutical products, namely, therapeutic proteins for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Mark Description:

N/A

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

06-03-2008

Mark Drawing Status:

Standart Character Mark

Abandon Date:

09-26-2011

Business Name:

BRISTOL-MYERS SQUIBB COMPANY

Correspondent Name:

Recent Trademark filings by this company